Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion type Assertion NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_head.
- NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion description "[We have used SKY for comprehensive analysis of 20 myelodysplastic syndromes (MDSs) (13 primary MDSs, 3 therapy-related MDSs, and 4 acute leukemias developed from MDS, including 1 cell line established from a secondary leukemia), previously analyzed by G-banding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_provenance.
- NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion evidence source_evidence_literature NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_provenance.
- NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion SIO_000772 10534769 NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_provenance.
- NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion wasDerivedFrom befree-2016 NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_provenance.
- NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_assertion wasGeneratedBy ECO_0000203 NP266112.RANkB4xtPOS6N9IbTJW3Es5gv3bxdhWKbd4iLQaFzcfRo130_provenance.